COVID19 Lessons Learned: Examining the Costs and Challenges for Managed Care Organizations and Health Systems


Jointly provided by
    Impact Education, LLC
This activity is supported by independent educational grants from AbbVie Inc. and GlaxoSmithKline Pharmaceutical Company.

LIVE Webcast Date
Friday, June 5, 2020
12:30 PM - 2:00 PM ET

Attendees: Click here to visit and submit an evaluation or claim credit

To join a webcast or complete an evaluation for a webcast you attended, please visit us at

  Learn About
  • The health care system response to COVID-19
  • Costs and challenges related to the management of COVID-19
  • Strategies to optimize costs and resource utilization
  Expert Faculty Presenters
Vanita Pindolia, PharmD, BCPS, MBA
Vice President, Ambulatory Clinical Pharmacy Programs_PCM
Henry Ford Health System/Health
Alliance Plan of Michigan
Mayur Ramesh, MD
Senior Staff Physician, Infectious Diseases
Henry Ford Health System
Peter Watson, MD, MMM, FACP, SFHM
Vice President, Care Management, Quality and Outcomes
Health Alliance Plan (HAP)
Medical Director, HAP/HAP Empowered
Attending Staff Hospitalist, Henry Ford Medical Group
  Who Should Attend?
  • Managed care medical directors, pharmacy directors, clinical pharmacists, specialty pharmacists, quality directors, as well as network physicians affiliated with various MCOs, health systems, and other payer organizations
  • Registered nurses, case managers, policy administrators, utilization managers, C-suite executives, and IT professionals.

  Statement of Need/Program Overview

The overall response to the COVID-19, the disease caused by SARS-CoV-2, demonstrated the lack of preparedness that many organizations had for a health care pandemic. Lessons learned from the COVID-19 crisis can serve valuable guidance for managed care organizations (MCOs) and various health systems so that they can better prepare for a pandemic situation. Several strategies emerged during the COVID-19 pandemic that are important to utilize and to optimize costs and resource utilization during pandemic situations. These include the increased use of telehealth, increased home delivery of medications, early refills, as well as transferring patients to homecare when possible. This educational activity is designed to improve the knowledge and competence among managed care and health system professionals regarding the need to develop a pandemic preparedness plan that includes these strategies to reduce cost and provide optimal patient care during a pandemic.

  Educational Objectives

At the conclusion of this activity, participants should be able to demonstrate improved ability to:
  • Evaluate the health care system response to COVID-19
  • Examine the costs and challenges related to the management of COVID-19
  • Apply strategies to optimize costs and resource utilization associated with the treatment and management of COVID-19

Date and Time
Friday, June 5, 2020
12:30 PM - 2:00 PM ET

Introduction – Initial Commentary & Overview
Vanita Pindolia, PharmD, BCPS, MBA
Current Status Update for the Treatment of COVID-19
Mayur Ramesh, MD
Costs and Challenges Related to the Management of COVID-19
Vanita Pindolia, PharmD, BCPS, MBA
Strategies to Optimize Costs and Resource Utilization for the Treatment and Management of COVID-19 and Future Pandemics
Peter Watson, MD, MMM, FACP, SFHM
Faculty Idea Exchange & Audience Question and Answer Session
Closing Commentary
  Accreditation Information
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Impact Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: JA4008162-9999-20-2146-L04-P
Type of Activity: Application

Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Hardware/Software Requirements
Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.0, and Google Chrome 10 and up.

Policy on Privacy and Confidentiality
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.

Fee Information
No additional fee is required to attend this CME/CPE/CNE activity.

If you have any questions, please call (215) 619-8812 or email